Doximity, Inc. DOCS
We take great care to ensure that the data presented and summarized in this overview for Doximity, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding DOCS
View all-
Black Rock Inc. New York, NY10.8MShares$537 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$535 Million0.01% of portfolio
-
Durable Capital Partners LP Bethesda, MD7.82MShares$390 Million2.56% of portfolio
-
William Blair Investment Management, LLC Chicago, IL6.47MShares$323 Million0.72% of portfolio
-
Baillie Gifford & CO5.36MShares$267 Million0.18% of portfolio
-
Morgan Stanley New York, NY5.34MShares$266 Million0.02% of portfolio
-
Clearbridge Investments, LLC New York, NY5.32MShares$265 Million0.19% of portfolio
-
State Street Corp Boston, MA3.69MShares$184 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.58MShares$179 Million0.09% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.55MShares$177 Million2.2% of portfolio
Latest Institutional Activity in DOCS
Top Purchases
Top Sells
About DOCS
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Insider Transactions at DOCS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 15
2024
|
Anna Bryson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,120
-1.68%
|
$266,240
$52.04 P/Share
|
|
Nov 15
2024
|
Jeffrey Tangney Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,087
-0.83%
|
$1,096,524
$52.04 P/Share
|
|
Nov 12
2024
|
Anna Bryson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
100,000
-6.97%
|
$5,800,000
$58.61 P/Share
|
|
Nov 12
2024
|
Anna Bryson Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
100,000
+11.99%
|
-
|
|
Nov 12
2024
|
Kevin Spain |
SELL
Other acquisition or disposition
|
Indirect |
4,051,932
-62.5%
|
-
|
|
Nov 12
2024
|
Kevin Spain |
BUY
Conversion of derivative security
|
Indirect |
3,858,182
+50.0%
|
-
|
|
Nov 01
2024
|
Kira Scherer Wampler Director |
SELL
Open market or private sale
|
Direct |
2,500
-13.08%
|
$105,000
$42.0 P/Share
|
|
Nov 01
2024
|
Kira Scherer Wampler Director |
BUY
Conversion of derivative security
|
Direct |
2,500
+11.56%
|
-
|
|
Nov 01
2024
|
Timothy S Cabral Director |
SELL
Open market or private sale
|
Direct |
20,000
-64.36%
|
$840,000
$42.07 P/Share
|
|
Nov 01
2024
|
Timothy S Cabral Director |
BUY
Conversion of derivative security
|
Direct |
20,000
+39.16%
|
-
|
|
Oct 24
2024
|
Jeffrey Tangney Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
252,234
+9.0%
|
-
|
|
Oct 01
2024
|
Kira Scherer Wampler Director |
SELL
Open market or private sale
|
Direct |
2,500
-13.08%
|
$107,500
$43.44 P/Share
|
|
Oct 01
2024
|
Kira Scherer Wampler Director |
BUY
Conversion of derivative security
|
Direct |
2,500
+11.56%
|
-
|
|
Sep 03
2024
|
Kira Scherer Wampler Director |
SELL
Open market or private sale
|
Direct |
2,500
-13.08%
|
$90,000
$36.27 P/Share
|
|
Sep 03
2024
|
Kira Scherer Wampler Director |
BUY
Conversion of derivative security
|
Direct |
2,500
+11.56%
|
-
|
|
Aug 29
2024
|
Kevin Spain |
BUY
Grant, award, or other acquisition
|
Direct |
6,360
+34.82%
|
-
|
|
Aug 29
2024
|
Watkin Phoebe L. Yang Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,360
+26.52%
|
-
|
|
Aug 29
2024
|
Kira Scherer Wampler Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,360
+27.68%
|
-
|
|
Aug 29
2024
|
Regina M. Benjamin Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,360
+27.68%
|
-
|
|
Aug 29
2024
|
Timothy S Cabral Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,360
+36.48%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 388K shares |
|---|---|
| Conversion of derivative security | 13.8M shares |
| Open market or private sale | 299K shares |
|---|---|
| Other acquisition or disposition | 11.8M shares |
| Payment of exercise price or tax liability | 39.4K shares |